Annual Drug Patent Expirations for ZOHYDRO+ER
Zohydro Er is a drug marketed by Persion and is included in one NDA. It is available from one supplier. There are fifteen patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for ZOHYDRO ER.
This drug has twenty patent family members in twelve countries.
The generic ingredient in ZOHYDRO ER is hydrocodone bitartrate. One supplier is listed for this compound. Additional details are available on the hydrocodone bitartrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com